Banking

Biogen Earnings, Sales Top Q2 Views; Stock Rises

Biogen stock rose slightly Thursday after the biotech company reported adjusted earnings of $5.68 per share on $2.78 in sales for its second quarter.




X



On average, analysts polled by FactSet expected Biogen (BIIB) to earn $4.55 per share on $2.61 billion in sales.

In the year-earlier period, Biogen earnings were $10.26 a share on $3.68 billion in sales.

For the year, Biogen guided to adjusted EPS of $17.50-$19. It raised its revenue target to $10.65 billion-$10.85 billion from $10.45 billion-$10.75 billion. Analysts called for adjusted profit of $18.50 per share and $10.61 billion in sales.

In premarket trading on the stock market today, Biogen stock rose 1.6%.

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.

YOU MAY ALSO LIKE:

Intuitive Surgical Stock Nears $1,000 As The Covid Recovery Continues

Johnson & Johnson Shrugs Off Vaccine Worries But Stays Flat Despite Quarterly Beat

Watch IBD’s Investing Strategies Show For Actionable Market Insights

IBD’s Leaderboard Is Celebrating 10 Years!

Options Trading: How To Start Using Options, How To Manage Risk



Most Related Links :
todayprimenews Governmental News Finance News

Source link

Back to top button